Brief: Renovorx Formation Of Renovocath Medical Advisory Board To Support Clinical And Strategic Initiatives
10/02/2026 13:51
Feb 10 (Reuters) - RenovoRx Inc RNXT.O: RENOVORX - FORMATION OF RENOVOCATH MEDICAL ADVISORY BOARD TO SUPPORT CLINICAL AND STRATEGIC INITIATIVES Source text: ID:nGNXbMGl1C Further company coverage: RNXT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on RenovoRx
See all newsBrief: RenovoRx Gets FDA Orphan Drug Designation For Oxaliplatin To Treat Pancreatic Cancer
RenovoRx Q1 revenue rises as number of active cancer centers increase
RenovoRx 2025 net loss widens on higher operating expenses
Brief: RenovoRx FY Net Income USD -11.168 Million
U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies